Saturday, November 25, 2023 1:16:50 PM
SENDS Technology logo
SENDS Technology
Self-Emulsifying Cannabinoid Delivery System.
Biotechnology Research
Chattanooga, Tennessee
223 followers
11-50 employees
Visit website
Home
About
Posts
Jobs
People
About
SENDS™ Technology enhances the effectiveness, efficacy, and user experience of cannabinoid products giving your customers value to meet their expectations. Of equal importance, we help your business launch truly differentiated and superior products with significant cost saving measures at scale.
SENDS™ (Self-Emulsifying Nano-Delivery System) Technology is a self-emulsifying permeability technology that increases absorption and bioavailability of fat soluble drugs and ingredients through topical, mucosal, and ingestible means. By converting the lipophilic state of the delivered ingredient to a hydrophilic state, the human body is able to better absorb the ingredient at site in seconds.
SENDS Tech powers hemp + cannabis-infused edibles, tinctures, topicals, beverages, and more without the need for expensive emulsion machinery.
$AURI final product labels! #OTCMarkets #CBD pic.twitter.com/P5CdOEYYIP
— Auri Inc (@AURI_OTC) October 31, 2023
Learn more:
www.SENDSTechnology.com
$AURI we own the recipe for this product. We are going to announce exactly what that means for the company. There will be revenues to announce as well. #OTCMarkets https://t.co/D8TWV04y8D
— Auri Inc (@AURI_OTC) July 20, 2023
https://float.sendstechnology.com/
Contact
sales@landracebio.com
+1 (706) 406-3128
Sends technology logo
© 2022 SENDS Technology, All Rights Reserved.
Dr. Noi Obias
Product Innovator & Technologist
Dr. Obias holds a PhD in bioinorganic and medicinal chemistry from Johns Hopkins University and a postdoctoral degree in enzymology, protein biochemistry, and functional genomics from Massachusetts Institute of Technology. He holds over 30 patents for drug delivery and CPG technologies.
Background
During his PhD and postdoctoral work, Dr. Obias focused his research on drug delivery systems for oil based ingredients, specifically designing a delivery matrix for doxycycline, an oil based malaria medication. Topical application required creating an emulsifying permeability technology for increased absorption by the body.
Experience
As professional product developer, Dr. Obias led product creation for global brands at Proctor & Gamble and Sanofi/ Chattem. While at P&G, he invented the technology for the launch of the Gillette Fusion razor, P&G's first brand to drive $1B in revenue in its first year.
Creation of SENDS
In 2019, Dr. Obias joined Landrace Bioscience where he developed and patented SENDS Technology: a prized product of his doctoral and postdoctoral medical research combined with over 25 years of product creation for global consumer healthcare, OTC, and CPG brands.
SENDS technology logo
©2022 SENDS Technology, All Rights Reserved.
Float Hemp-Derived Smart Shroom Gummies
Powered by rapid onset SENDS™ Technology
SPECIFICATIONS:
– FLAVORS –
TRIPPY HIPPY
BOHEMIAN BERRY
MAGIC LOVE
5-gram blend of hemp-derived D9, functional mushrooms
Vegan/Pectin-based gummies, all-natural flavoring
Die-cut mushroom package with foil
10 gummies per bag
10 gummy bags per POP box
10 POP boxes per Master Case
PRICING (MOQs):
1-10 Master Cases: $500/case
11-29 Master Cases: $450/case
30-49 Master Cases: $400/case
50 Master Cases and above (Distributor Pallet Price): $360/case
float shot bottles copy
Float Hemp-Derived Smart Shroom Drink Shots
SPECIFICATIONS:
– FLAVORS –
BLUE LOTUS
SHROOMBERRY
TRIPS AHOY
2 ounce drink shot blend, hemp-derived D9 THC, functional mushrooms
Potency: 25mg D9 THC, 1 shot = 1 serving
12 shots per POP box
12 POPS per Master Case
Pallet holds 75 Master Cases
PRICING (MOQs):
1 Master Case (144 bottles): $720/case
2-25 Master Cases: $648/case
26-74 Master Cases: $576/case
75+ Master Cases (Distributor Pallet Price): $504/case
PLACE YOUR ORDER NOW
Smart Shroom Gummies:
Trippy Hippy
Bohemian Berry
Magic Love
1-10 Master cases
11-29 Master cases
30-49 Master cases
50+ Master cases
Smart Shroom Drink Shots:
Blue Lotus
Shroomberry
Trips Ahoy
1 Master Case
2-25 Master Cases
26-74 Master Cases
75+ Master Cases
First Name*
Last Name*
Email*
Phone Number*
Street Address*
City*
State/Region*
Postal Code*
Country/Region*
Company Name
Order/Shipping Terms:
All orders over $100 are eligible for free shipping with freight. Expedited shipping has an additional cost.
Lead Time: Current lead time is 1-2 weeks. Please note this product is in high demand and production runs sell out quickly. To avoid potential queue delays, it is recommended to place your order in advance.
Payment: Full payment upfront is required for wholesale orders less than one (1) pallet.
We accept credit cards and wire transfers. We do NOT accept checks or money orders.
Distributor Pallet Orders: 50% deposit upfront, remaining balance due prior to shipment.
$AURI final product labels! #OTCMarkets #CBD pic.twitter.com/P5CdOEYYIP
— Auri Inc (@AURI_OTC) October 31, 2023
Notice who manufactured Eddie Vakser's samples. Landrace Bioscience the manufacturer and they have the patented Sends Technology.
Recent AURI News
- Auri Inc. ("AURI") Appoints Bon Halder as Interim CEO to Lead Energy-Focused Execution Strategy • ACCESS Newswire • 04/22/2026 12:33:00 PM
- Auri Inc. ("AURI") Announces CEO Candidate Discussions and Continued Strategic Progress • ACCESS Newswire • 04/15/2026 02:55:00 PM
- Auri Inc ("AURI") New Management And Business Focus • ACCESS Newswire • 04/13/2026 12:30:00 PM
- Auri Inc. ("AURI") Negotiates Oil and Gas Deal in Moldova • ACCESS Newswire • 03/27/2026 12:33:00 PM
- Auri Inc ("Auri") New Acquisition Record Date • ACCESS Newswire • 02/27/2026 01:33:00 PM
- Auri Inc ("AURI") New Acquisition Completed • ACCESS Newswire • 02/24/2026 01:30:00 PM
- Auri Inc. (OTCID: AURI) to Present Business Initiative and Corporate Plan at BFCVC 3 - February 18, 2026, at 12:00 PM EST • ACCESS Newswire • 02/17/2026 01:34:00 PM
- Black Dragon(BDGR) Invites Shareholders to Join Auri Inc in Strategic Financial Updates • ACCESS Newswire • 02/17/2026 01:34:00 PM
- Auri Inc ("AURI") Announces Completion of Corporate Acquisition $ 5.7 million in added revenues and $7.5 million Revenue projected for 2026 • ACCESS Newswire • 02/11/2026 01:43:00 PM
- Auri Inc ("AURI") New Acquisition Transfer Completed, Revenue Progress Report • ACCESS Newswire • 02/09/2026 01:15:00 PM
- Auri Inc ("AURI") Releases Corporate Update Regarding subsidiary Companies • ACCESS Newswire • 02/02/2026 01:43:00 PM
- Auri Inc ("AURI") Continues to Grow its Subsidiary Companies Holdings and their Business Operations • ACCESS Newswire • 01/21/2026 01:15:00 PM
- SUTI to Acquire a Division of Auri Inc., Shareholders Corporate Updates • ACCESS Newswire • 01/14/2026 01:35:00 PM
- Auri Inc ("AURI") Shareholders Updates; Company and Subsidiaries Growth Activities and New Initiatives • ACCESS Newswire • 01/14/2026 01:35:00 PM
- Auri Inc ("AURI") Presents Revenues Projections, Company and Subsidiaries Growth Activities and New Initiatives • ACCESS Newswire • 01/05/2026 01:35:00 PM
- BDGR Announces Revenue Producing Acquisitions and Management Financial Updates • ACCESS Newswire • 12/31/2025 01:35:00 PM
- Auri Inc ("Auri") Presents End of the Year Company Updates for New Year 2026 • ACCESS Newswire • 12/31/2025 01:30:00 PM
- Shareholders Updates • ACCESS Newswire • 12/22/2025 01:41:00 PM
- Shareholders Update Report • ACCESS Newswire • 12/22/2025 01:37:00 PM
